Real-time quantification of Xeroderma pigmentosum mRNA from the mammalian cochlea

Ear and Hearing

Volumn 31, Issue 5, 2010, Pages 714-721

  Guthrie, O'Neil W ^a,b,c,d   Carrero Martínez, Franklin A ^a,e,f  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c University of Pittsburgh School of Medicine   (United States)

^d Jerry L Pettis Memorial VA Medical Center   (United States)

^e UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^f UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DNA BINDING PROTEIN; MESSENGER RNA; XPA PROTEIN, RAT; XPC PROTEIN, RAT;

ANIMAL; ARTICLE; COCHLEA; DNA REPAIR; FISCHER 344 RAT; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY; MAMMAL; METABOLISM; PHYSIOLOGY; RAT;

ANIMALS; CARRIER PROTEINS; COCHLEA; DNA REPAIR; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; MAMMALS; RATS; RATS, INBRED F344; RNA, MESSENGER;

EID: 77956423644     PISSN: 01960202     EISSN: None     Source Type: Journal    
DOI: 10.1097/AUD.0b013e3181ddf5a3     Document Type: Article

References (47)

1. Balajee, A., & Bohr, V. (2000). Genomic heterogeneity of nucleotide excision repair. Gene, 250, 15-30.
2. Bánfi, B., Malgrange, B., Knisz, J., et al. (2004). NOX3, a superoxidegenerating NADPH oxidase of the inner ear. J Biol Chem, 279, 46065-46072.
3. Bedard, K., & Krause, K. H. (2007). The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev, 87, 245-313.
4. Brammer, I., Herskind, C., Haase, O., et al. (2004). Induction and repair of radiation-induced DNA double-strand breaks in human fibroblasts are not affected by terminal differentiation. DNA Repair (Amst), 3, 113-120.
5. Brooks, P. J. (2007). The case for 8,5̈-cyclopurine-2̈- deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience, 145, 1407-1417.
6. Brooks, P. J., Wise, D. S., Berry, D. A. (2000). The oxidative DNA lesion 8,5̈-(S)-cyclo-2̈-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J Bio Chem, 275, 22355-22362.
7. Cheng, P. W., Kaga, K., Koyama, S. (2001). Temporal bone histopathology after treatment by a large amount of cisplatin: A case study. Otolaryngol Head Neck Surg, 125, 411-413.
8. Dmitrieva, N. I., Burg, M. B., Ferraris, J. D. (2005). DNA damage and osmotic regulation in the kidney. Am J Physiol Renal Physiol, 289, 2-7.
9. el Barbary, A., Altschuler, R. A., Schacht, J. (1993). Glutathione Stransferases in the organ of Corti of the rat: Enzymatic activity, subunit composition and immunohistochemical localization. Hear Res, 71, 80-90.
10. Evans, E., Moggs, J. G., Hwang, J. R. (1997). Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J, 16, 6559-6573.
11. García-Berroca, l, J. R., Nevado, J., Ramírez-Camacho, R., et al. (2007). The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear. Br J Pharmacol, 152, 1012-1020.
12. Gospodinov, A., Ivanov, R., Anachova, B. (2003). Nucleotide excision repair in rat tissues: Eur J Biochem, 270, 1000-1005.
13. Guthrie, O. W. (2008a). Aminoglycoside induced ototoxicity. Toxicology, 249, 91-96.
14. Guthrie, O. W. (2008b). Dys-synchronous regulation of XPC and XPA among trigeminal ganglion neurons following cisplatin treatment cycles. Anticancer Res, 28, 2637-2640.
15. Guthrie, O. W. (2008c). Preincision complex-I from the excision nuclease reaction among cochlear spiral limbus and outer hair cells. J Mol Histol, 39, 617-625.
16. Guthrie, O. W. (2009). DNA repair proteins and telomerase reverse transcriptase in the cochlear lateral wall of cisplatin treated rats. J Chemother, 21, 74-79.
17. Guthrie, O. W., Li-Korotki, H.-S., Durrant, J. D., et al. (2008). Cisplatin induces cytoplasmic to nuclear translocation of nucleotide excision repair factors among spiral ganglion neurons. Hear Res, 239, 79-91.
18. Hoistad, D. L., Ondrey, F. G., Mutlu, C. (1998). Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol Head Neck Surg, 118, 825-832.
19. Kassam, S. N., & Rainbow, A. J. (2007). Deficient base excision repair of oxidative DNA damage induced by methylene blue plus visible light in xeroderma pigmentosum group C fibroblasts. Biochem Biophys Res Commun, 359, 1004-1009.
20. Kenyon, G. S., Booth, J. B., Prasher, D. K. (1985). Neuro-otological abnormalities in xeroderma pigmentosum with particular reference to deafness. Brain, 108, 771-784.
21. Kopke, R., Allen, K. A., Henderson, D. (1999). A radical demise: Toxins and trauma share common pathways in hair cell death. Anal N Y Acad Sci, 884, 171-191.
22. Kuraoka, I., Bender, C., Romieu, A., et al. (2000). Removal of oxygen free-radical-induced 5̈8-purine cyclodeoxynucleoside from DNA by the nucleotide excision-repair pathway in human cells. PNAS, 97, 3832-3837.
23. Lautermann, J., Crann, S. A., McLaren, J., et al. (1997). Glutathionedependent antioxidant systems in the mammalian inner ear: Effects of aging, ototoxic drugs and noise. Hear Res, 114, 75-82.
24. Lehmann, A. L. (2001). The xeroderma pigmentosum group D (XPD) gene: One gene, two functions three diseases. Genes Develop, 15, 15-23.
25. Moné, M. J., Bernas, T., Dinant, C., et al. (2004). In vivo dynamics of chromatin-associated complex formation in mammalian nucleotide excision repair. PNAS, 101, 15933-15937.
26. Oh, K. S., Khan, S. G., Jaspers, N. G. (2006). Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): Xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat, 27, 1092-1103
27. Politi, A., Moné, M. J., Houtsmuller, A. B., et al. (2005). Mathematical modeling of nucleotide excision repair reveals efficiency of sequential assembly strategies. Mol Cell, 19, 679-690.
28. Rademakers, S., Volker, M., Hoogstraten, D., et al. (2003). Xeroderma pigmentosum group A protein loads as a separate factor onto DNA lesions. Mol Cell Biol, 23, 5755-5767.
29. Rapin, I., Lindenbaum, Y., Dickson, D. W., et al. (2000). Cockayne syndrome and xeroderma pigmentosum: DNA repair disorders with overlaps and paradoxes. Neurology, 55, 1442-1449.
30. Reardon, J. T., Bessho, T., Kung. H. C., et al. (1997). In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc Natl Acad Sci U S A, 95, 9463-9468.
31. Riedl, T., Hanaoka, F., Egly, J. M. (2003). The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J, 22, 5293-5303.
32. Robbins, H., Brumback, R. A., Mendiones, M., et al. (1991). Neurologic disease in xeroderma pigmentosum: Documentation of a late onset type of the juvenile onset form. Brain, 114, 1335-1361.
33. Rybak, L. P., Whitworth, C. A., Mukherjea, D., et al. (2007). Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res, 226, 157-167.
34. Schmittgen, T. D., & Livak, K. J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 3, 1101-1108.
35. Schmittgen, T. D., Zakrajsek, B. A., Mills, A. G. (2000). Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods. Anal Biochem, 285, 194-204.
36. States, J. C., & Reed, E. (1996). Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplifications. Cancer Lett, 108, 233-237.
37. Sugasawa, K., Ng, J. M., Masutani, C., et al. (1998). Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell, 2, 223-232.
38. Sugasawa, K. (2008). Xeroderma pigmentosum genes: Functions inside and outside DNA repair. Carcinogenesis, 29, 455-465.
39. Takumida, M., & Anniko, M. (2001). Direct evidence of nitric oxide production in the guinea pig organ of Corti. Acta Otolaryngol, 121, 342-345.
40. Thoma, B. S., & Vasquez, K. M. (2003). Critical DNA damage recognition functions of XPC-hHR23b and XPA-RPA in nucleotide excision repair. Mol Carcinogen, 38, 1-13.
41. Thomas, J. P., Lautermann, J., Liedert, B., et al. (2006). High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity. Mol Pharmacol, 70, 23-29.
42. Tiede, L. M., Rocha-Sanchez, S. M., Hallworth, R. (2007). Determination of hair cell metabolic state in isolated cochlear preparations by twophoton microscopy. J Biomed Opt, 12, 1-15.
43. van den Berg, J. H., Beijnen, J. H., Balm, A. J. (2006). Future opportunities in preventing cisplatin induced ototoxicity. Cancer Treat Rev, 32, 390-397.
44. van Ruijven, M. W. M., de Groot, J. C. M. J., Hendriksen, F. (2005). Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs. Hear Res, 203, 112-121.
45. Weaver, D. A., Crawford, E. L., Warner, K. A., et al. (2005). ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. Mol Cancer, 4, 18-26.
46. Winkler, G. S., Araújo, S. J., Fiedler, U., et al. (2000). TFIIH with inactive XPD helicase functions in transcription initiation but is defective in DNA repair. J Biol Chem, 275, 4258-4266.
47. Wu, X., Shell, S. M., Liu, Y., et al. (2007). ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation. Oncogene, 26, 757-764.